Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer
- 1 October 2020
- Vol. 16 (39), e2001450
- https://doi.org/10.1002/smll.202001450
Abstract
The identification of a highly sensitive method to check the delivery of administered nanodrugs into the tumor cells is a crucial step of preclinical studies aimed to develop new nanoformulated cures, since it allows the real therapeutic potential of these devices to be forecast. In the present work, the ability of an H-ferritin (HFn) nanocage, already investigated as a powerful tool for cancer therapy thanks to its ability to actively interact with the transferrin receptor 1, to act as an efficient probe for the monitoring of nanodrug delivery to tumors is demonstrated. The final formulation is a bioluminescent nanoparticle, where the luciferin probe is conjugated on nanoparticle surface by means of a disulfide containing linker (Luc-linker@HFn) which is subjected to glutathione-induced cyclization in tumor cell cytoplasm. The prolonged imaging of luciferase+ tumor models, demonstrated by an in vitro and an in vivo approach, associated with the prolonged release of luciferin into cancer cells by disulfide bridge reduction, clearly indicates the high efficiency of Luc-linker@HFn for drug delivery to the tumor tissues.Funding Information
- Associazione Italiana per la Ricerca sul Cancro (21565)
- Fondazione Cariplo
- Regione Lombardia (2016‐0886)
- Ministero dell’Istruzione, dell’Università e della Ricerca
This publication has 26 references indexed in Scilit:
- Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicityOncotarget, 2016
- Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancerPharmacological Research, 2016
- Ferritin family proteins and their use in bionanotechnologyNew Biotechnology, 2015
- IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic CancerACS Nano, 2015
- H‐Chain Ferritin: A Natural Nuclei Targeting and Bioactive Delivery NanovectorAdvanced Healthcare Materials, 2015
- Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer CellsJournal of Controlled Release, 2014
- H-ferritin–nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injectionProceedings of the National Academy of Sciences of the United States of America, 2014
- Ferritin Nanocages To Encapsulate and Deliver Photosensitizers for Efficient Photodynamic Therapy against CancerACS Nano, 2013
- RGD-Modified Apoferritin Nanoparticles for Efficient Drug Delivery to TumorsACS Nano, 2013
- Magnetoferritin nanoparticles for targeting and visualizing tumour tissuesNature Nanotechnology, 2012